Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiping He

Showing results (131-140 of 145) with videos related to

Pageof 15
Sort By:
Blood|August 3, 2007
Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1Bas J Wouters, Meritxell Alberich Jordà, Karen Keeshan, et al.
Oncotarget|April 12, 2014
Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomasPatrick J Killela, Christopher J Pirozzi, Patrick Healy, et al.
Nature Genetics|June 2, 2014
Exome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomasLiwei Zhang, Lee H Chen, Hong Wan, et al.
Nature Communications|June 20, 2020
The integrated genomic and epigenomic landscape of brainstem gliomaLee H Chen, Changcun Pan, Bill H Diplas, et al.
BMC Cancer|June 28, 2022
A study protocol of a randomized phase II trial of perioperative chemoimmunotherapy verses perioperative chemoimmunotherapy plus preoperative chemoradiation for locally advanced gastric (G) or gastroesophageal junction (GEJ) adenocarcinoma: the NeoRacing studyMenglong Zhou, Wang Yang, Yan Xuan, et al.
Nature Communications|May 27, 2018
The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastomaBill H Diplas, Xujun He, Jacqueline A Brosnan-Cashman, et al.
Biorxiv : the Preprint Server for Biology|May 3, 2023
Interplay between <i>ATRX</i> and <i>IDH1</i> mutations governs innate immune responses in diffuse gliomasSeethalakshmi Hariharan, Benjamin T Whitfield, Christopher J Pirozzi, et al.
Nature Communications|January 25, 2024
Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomasSeethalakshmi Hariharan, Benjamin T Whitfield, Christopher J Pirozzi, et al.
Nature Communications|January 14, 2021
Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapyMatthias Gromeier, Michael C Brown, Gao Zhang, et al.
Science (New York, N.Y.)|July 2, 2011
Altered telomeres in tumors with ATRX and DAXX mutationsChristopher M Heaphy, Roeland F de Wilde, Yuchen Jiao, et al.
Pageof 15

Showing results (131-140 of 145) with videos related to

Sort By:
Pageof 15
Blood|August 3, 2007
Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1Bas J Wouters, Meritxell Alberich Jordà, Karen Keeshan, et al.
Oncotarget|April 12, 2014
Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomasPatrick J Killela, Christopher J Pirozzi, Patrick Healy, et al.
Nature Genetics|June 2, 2014
Exome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomasLiwei Zhang, Lee H Chen, Hong Wan, et al.
Nature Communications|June 20, 2020
The integrated genomic and epigenomic landscape of brainstem gliomaLee H Chen, Changcun Pan, Bill H Diplas, et al.
BMC Cancer|June 28, 2022
A study protocol of a randomized phase II trial of perioperative chemoimmunotherapy verses perioperative chemoimmunotherapy plus preoperative chemoradiation for locally advanced gastric (G) or gastroesophageal junction (GEJ) adenocarcinoma: the NeoRacing studyMenglong Zhou, Wang Yang, Yan Xuan, et al.
Nature Communications|May 27, 2018
The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastomaBill H Diplas, Xujun He, Jacqueline A Brosnan-Cashman, et al.
Biorxiv : the Preprint Server for Biology|May 3, 2023
Interplay between <i>ATRX</i> and <i>IDH1</i> mutations governs innate immune responses in diffuse gliomasSeethalakshmi Hariharan, Benjamin T Whitfield, Christopher J Pirozzi, et al.
Nature Communications|January 25, 2024
Interplay between ATRX and IDH1 mutations governs innate immune responses in diffuse gliomasSeethalakshmi Hariharan, Benjamin T Whitfield, Christopher J Pirozzi, et al.
Nature Communications|January 14, 2021
Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapyMatthias Gromeier, Michael C Brown, Gao Zhang, et al.
Science (New York, N.Y.)|July 2, 2011
Altered telomeres in tumors with ATRX and DAXX mutationsChristopher M Heaphy, Roeland F de Wilde, Yuchen Jiao, et al.
Pageof 15